A new study looks at the effects of telephone-delivered depression care management in postpartum women.  The July issue of Birth Defects Research features a collection of reviews on perinatal mental health.  

Telephone-Based Depression Care Management for Postpartum Women: A Randomized Controlled Trial.

Wisner KL, Sit DKY, McShea M, Luther JF, Eng HF, Dills JL, Moses-Kolko EL, Wisniewski SR.  J Clin Psychiatry. 2017 Aug 8.

In women with postpartum depression, clinicians compared telephone-delivered depression care management (DCM) to enhanced usual care(EUC). Both DCM and EUC favorably impacted depression symptom levels and function.

Selective Serotonin Reuptake Inhibitors during Pregnancy: Do We Have Now More Definite Answers Related to Prenatal Exposure?

Ornoy A, Koren G.  Birth Defects Res. 2017 Jul 17;109(12):898-908. Review.

Use of Psychotropic Medications in Breastfeeding Women.

Kronenfeld N, Berlin M, Shaniv D, Berkovitch M.  Birth Defects Res. 2017 Jul 17;109(12):957-997.

Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure.  

Rotem-Kohavi N, Oberlander TF.  Birth Defects Res. 2017 Jul 17;109(12):909-923.  Review.

Depression and Its Treatment During Pregnancy: Overview and Highlights.

Howdeshell KL, Ornoy A.  Birth Defects Res. 2017 Jul 17;109(12):877-878.

Antidepressants, Antipsychotics, and Mood Stabilizers in Pregnancy: What Do We Know and How Should We Treat Pregnant Women with Depression.

Ornoy A, Weinstein-Fudim L, Ergaz Z.  Birth Defects Res. 2017 Jul 17;109(12):933-956.  Review.

Neurobehavioral risks of SSRIs in pregnancy: Comparing human and animal data.

Ornoy A.  Reprod Toxicol. 2017 Sep;72:191-200. Epub 2017 May 8.

Is it safe to use lamotrigine during pregnancy? A prospective comparative observational study.

Diav-Citrin O, Shechtman S, Zvi N, Finkel-Pekarsky V, Ornoy A.  Birth Defects Res. 2017 Sep 1;109(15):1196-1203. Epub 2017 Jun 28.

The rate of major congenital anomalies was similar between 218 lamotrigine exposed pregnancies (208 in the first trimester) and 865 non-exposed pregnancies. There was no case of oral cleft in the lamotrigine-exposed group.

The Postpartum Partner Support Scale: Development, psychometric assessment, and predictive validity in a Canadian prospective cohort.

Dennis CL, Brown HK, Brennenstuhl S.  Midwifery. 2017 Jul 29;54:18-24.

Following further psychometric testing, the Postpartum Partner Support Scale may be used to (1) identify women with inadequate partner support who are at risk for poor mental health, (2) individualise postnatal care, and (3) evaluate preventive interventions.

Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.

Weiser M, Levi L, Burshtein S, Hagin M, Matei VP, Podea D, Miclu?ia I, Tiugan A, P?cal? B, Grecu IG, Noy A, Zamora D, Davis JM.  J Clin Psychiatry. 2017 Jul;78(7):e758-e765.

The estrogen receptor modulator raloxifene did not appear to benefit postmenopausal women with schizophrenia.  

 

Related Posts